Related Experiment Video
Updated: May 7, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
NF-κB RelB negatively regulates osteoblast differentiation and bone formation
Zhenqiang Yao1, Yanyun Li, Xiaoxiang Yin
1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA; Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
Abstract:
RelA-mediated NF-κB canonical signaling promotes mesenchymal progenitor cell (MPC) proliferation, but inhibits differentiation of mature osteoblasts (OBs) and thus negatively regulates bone formation. Previous studies suggest that NF-κB RelB may also negatively regulate bone formation through noncanonical signaling, but they involved a complex knockout mouse model, and the molecular mechanisms involved were not investigated. Here, we report that RelB(-/-) mice develop age-related increased trabecular bone mass associated with increased bone formation. RelB(-/-) bone marrow stromal cells expanded faster in vitro and have enhanced OB differentiation associated with increased expression of the osteoblastogenic transcription factor, Runt-related transcription factor 2 (Runx2). In addition, RelB directly targeted the Runx2 promoter to inhibit its activation. Importantly, RelB(-/-) bone-derived MPCs formed bone more rapidly than wild-type cells after they were injected into a murine tibial bone defect model. Our findings indicate that RelB negatively regulates bone mass as mice age and limits bone formation in healing bone defects, suggesting that inhibition of RelB could reduce age-related bone loss and enhance bone repair.
Insights
Nuclear factor-kappa B (NF-κB) RelB protein inhibits bone formation. RelB deficiency in mice leads to increased bone mass and enhanced bone repair, suggesting RelB inhibition for treating bone loss.
Area of Science:
- Cell Biology
- Molecular Biology
- Bone Biology
Background:
- Nuclear factor-kappa B (NF-κB) signaling pathways play critical roles in bone metabolism.
- While RelA-mediated NF-κB signaling is known to affect bone formation, the role of NF-κB RelB in this process remains less understood.
- Previous studies on RelB's role in bone formation utilized complex models and did not elucidate underlying molecular mechanisms.
Purpose of the Study:
- To investigate the role of NF-κB RelB in regulating bone mass and formation.
- To elucidate the molecular mechanisms by which RelB influences osteoblast differentiation and bone repair.
Main Methods:
- Utilized RelB knockout (RelB(-/-)) mice to study age-related bone mass changes.
- Assessed mesenchymal progenitor cell (MPC) proliferation and osteoblast (OB) differentiation in vitro.
- Analyzed the expression of Runt-related transcription factor 2 (Runx2) in RelB(-/-) cells.
- Investigated the direct interaction of RelB with the Runx2 promoter.
- Evaluated bone formation in a murine tibial bone defect model using RelB(-/-) bone-derived MPCs.
Main Results:
- RelB(-/-) mice exhibited increased trabecular bone mass and enhanced bone formation with age.
- RelB(-/-) bone marrow stromal cells showed increased proliferation and enhanced OB differentiation.
- RelB(-/-) cells displayed increased expression of the osteoblastogenic transcription factor Runx2.
- RelB was found to directly target and inhibit the activation of the Runx2 promoter.
- Bone defects healed more rapidly in mice injected with RelB(-/-) MPCs compared to wild-type controls.
Conclusions:
- NF-κB RelB negatively regulates bone mass during aging.
- RelB limits bone formation in healing bone defects.
- Inhibition of RelB presents a potential therapeutic strategy for reducing age-related bone loss and improving bone repair.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Osteoclasts in Bone Remodeling
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-kB-dependent Signaling Pathway
Bone Remodeling

